Siga Technologies (SIGA) Work In Process (2019 - 2025)
Siga Technologies' (SIGA) quarterly Work In Process came in at $41.2 million in Q4 2025, up 2.02% on a YoY basis from $40.4 million in Q4 2024, and up 37.6% quarter-over-quarter from $30.0 million in Q3 2025.
Analysis
Siga Technologies (SIGA) Work In Process (2019 - 2025) Analysis & Trends
Siga Technologies (SIGA) has reported Work In Process for 7 consecutive years, with $41.2 million the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Work In Process rose 2.02% year-over-year to $41.2 million; the trailing twelve-month figure through Dec 2025 stood at $41.2 million (up 2.02% YoY), and the FY2025 full-year result was $41.2 million, up 2.02% from the prior year.
- Work In Process advanced to $41.2 million in Q4 2025 per SIGA's latest filing, from $30.0 million in the prior quarter.
- Across five years, Work In Process topped out at $57.9 million in Q1 2024 and bottomed at $9.3 million in Q2 2022.
- Historically, Work In Process has averaged $33.8 million across 5 years, with a median of $29.9 million in 2025.
- The sharpest annual moves came in 2021 and 2022: Work In Process jumped 1590.07% in 2021, then sank 47.96% in 2022.
- Over 5 years, Work In Process stood at $17.5 million in 2021, then soared by 54.92% to $27.0 million in 2022, then surged by 98.42% to $53.6 million in 2023, then fell by 24.66% to $40.4 million in 2024, then grew by 2.02% to $41.2 million in 2025.
- According to Business Quant data, Work In Process over the past three periods registered $41.2 million, $30.0 million, and $29.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 41.23 Mn |
| Sep 30, 2025 | 29.97 Mn |
| Jun 30, 2025 | 29.90 Mn |
| Mar 31, 2025 | 41.42 Mn |
| Dec 31, 2024 | 40.42 Mn |
| Sep 30, 2024 | 51.42 Mn |
| Jun 30, 2024 | 54.99 Mn |
| Mar 31, 2024 | 57.89 Mn |
| Dec 31, 2023 | 53.65 Mn |
| Sep 30, 2023 | 54.98 Mn |
| Jun 30, 2023 | 37.45 Mn |
| Mar 31, 2023 | 28.00 Mn |
| Dec 31, 2022 | 27.04 Mn |
| Sep 30, 2022 | 25.08 Mn |
| Jun 30, 2022 | 9.29 Mn |
| Mar 31, 2022 | 14.72 Mn |
| Dec 31, 2021 | 17.45 Mn |
| Sep 30, 2021 | 28.01 Mn |
| Jun 30, 2021 | 17.84 Mn |
| Mar 31, 2021 | 15.70 Mn |